Your browser doesn't support javascript.
loading
A Novel Doxorubicin Prodrug with GRP78 Recognition and Nucleus-Targeting Ability for Safe and Effective Cancer Therapy.
Ding, Guo-Bin; Sun, Junqing; Yang, Peng; Li, Binchun; Gao, Ying; Li, Zhuoyu.
Afiliação
  • Ding GB; Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Shanxi University , Taiyuan 030006, China.
  • Sun J; Institutes of Biomedical Sciences, Shanxi University , Taiyuan 030006, China.
  • Yang P; Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Shanxi University , Taiyuan 030006, China.
  • Li B; Institutes of Biomedical Sciences, Shanxi University , Taiyuan 030006, China.
  • Gao Y; Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Shanxi University , Taiyuan 030006, China.
  • Li Z; Institutes of Biomedical Sciences, Shanxi University , Taiyuan 030006, China.
Mol Pharm ; 15(1): 238-246, 2018 01 02.
Article em En | MEDLINE | ID: mdl-29207873
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Doxorrubicina / Proteínas de Choque Térmico Limite: Animals / Humans / Male Idioma: En Revista: Mol Pharm Assunto da revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Doxorrubicina / Proteínas de Choque Térmico Limite: Animals / Humans / Male Idioma: En Revista: Mol Pharm Assunto da revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China